Republic of the Philippines

Cebu Normal University Osmeña

Blvd., Cebu City, 6000, Philippines

College of Nursing
Telephone No.: (+63 32) 254 4837
Email: cn@cnu.edu.ph
Website: www.cnu.edu.ph

DRUG STUDY

Patient’s Initials: _J.C._______________ Date of Admission: _March 1, 2022 _____ Diagnosis: Osteoporosis_ Age: _66 years old_ Height: 5’2”_ Weight.: __110 lbs___ Clinical Intervention:
_______________ Sex: ___Female___________________ Ward: Oncology Bed No.: _2_ Name of Physician: Dr. Arnold Gerrard Suarez__________________________________________
Drug Information Classification Mechanism of Action Indication Contraindications Side Effects Nursing Responsibilities

Generic Name: Pharmacologic Pharmacodynamics or General Contraindicated in CNS: headache, Before Drug Administration:
Ibuprofen Classification: Mechanism of Action: Indication/s: patients hypersensitive to dizziness,
Non-opioid drug or in those who nervousness, aseptic  Instruct client to not drive or engage in other
Trade Name: Analgesic It inhibits the It is indicated for meningitis. potentially hazardous activities until response to
prostaglandin synthesis. have the syndrome of
Advil management of chronic, CV: peripheral the drug is known.
Therapeutic Prototype of the symptomatic rheumatoid nasal polyps, edema, fluid retention,
propionic acid NSAIDs angioedema, and  Instruct client to not self-medicate with ibuprofen if
Maximum Dose: Classification: arthritis and edema.
1200mg (OTC), Antipyretics, (cox-1) inhibitor with osteoarthritis; relief of bronchospastic reaction EENT: tinnitus. taking prescribed drugs or being treated for a
3200 (Prescription) Antirheumatics, non-steroidal anti- mild to moderate pain; to aspirin or other GI: epigastric distress, serious condition without consulting physician.
inflammatory activity and
Nonopioid primary dysmenorrhea; NSAIDs. Contraindicated nausea, occult blood Emphasize that drug must not be taken multiple
significant antipyretic
Minimum Dose: analgesics, reduction of fever. during the last trimester loss, peptic ulceration, doses/times/tabs at once.
and analgesic
200mg (OTC), Nonsteroidal properties. Ibuprofen diarrhea, constipation,  Instruct to avoid taking ibuprofen with aspirin
of pregnancy because it
400mg Anti- activity also includes dyspepsia, flatulence,
may cause problems with concurrently.
(Prescription) inflammatory modulation of T-cell heartburn, decreased
agents Patient’s the fetus or complications appetite.  Instruct client to avoid alcohol and NSAIDs unless
function, inhibition of
Patient’s Dose: inflammatory cell Indication: during delivery. GU: acute renal otherwise advised by physician. Concurrent use
400mg 1 tab chemotaxis, decreased failure, azotemia, may increase risk of GI ulceration and bleeding
release of superoxide Management of pain Precautions: Use cystitis, hematuria. tendencies.
Route: radicals, or increased cautiously in patients with Hematologic:  Note: Tablet may be crushed if patient is unable to
PO scavenging of these prolonged bleeding
impaired renal or hepatic swallow it whole and mixed with food or liquid
compounds at time, anemia,
inflammatory sites. function, GI disorders, neutropenia, before swallowing.
peptic ulcer disease, pancytopenia,
Therapeutic Effects: cardiac decompensation, thrombocytopenia,
Decreased pain and hypertension, or aplastic anemia, During and After Drug Administration:
inflammation. Reduction coagulation defects. leukopenia,
of fever. agranulocytosis.  Give on an empty stomach, 1 h before or 2 h after
Because chewable
Respiratory: meals. May be taken with meals or milk if GI
tablets contain
bronchospasm. intolerance occurs. Ensure that chewable tablets

Pharmacokinetics:
Absorption:
80% of oral dose is
absorbed from GI tract.
Distribution:
Highly protein-bouond
Metabolism and Excretion:
Undergoes bio-
transformation in the liver.
Excreted mainly in urine,
with some biliary excretion.
Plasma half-life ranges from
2 to 4 hours.
aspartame, use
cautiously in patients with
phenylketonuria.
Drug - Drug Interactions
ACE inhibitors: Reduces
response when used
together; may result in
acute reduction in renal
function.
Acetaminophen, gold
compounds, other anti-
inflammatories: May
increase nephrotoxicity.
Antacids: May decrease
absorption of ibuprofen.
Patient should take drugs
at separate times.
Anticoagulants,
thrombolytics (coumarin
derivatives, heparin,
streptokinase, urokinase):
Increase anticoagulant
effects. Monitor
coagulation studies.
Dosage adjustment may
be needed.
Antihypertensives,
diuretics: May decrease
effectiveness of these
drugs; diuretics may
increase nephrotoxicity.
Aspirin, carbenicillin,
cefamandole,
cefoperazone,
corticosteroids, dextran,
dipyridamole, mezlocillin,
piperacillin, plicamycin,
Skin: pruritus, rash, are chewed or crushed before being swallowed.
urticaria, Stevens-  Instruct client to notify physician immediately of
Johnson syndrome. passage of dark tarry stools, "coffee ground"
emesis, frankly bloody emesis, or other GI distress,
as well as blood or protein in urine, and onset of
skin rash, pruritus, jaundice.
 Monitor for therapeutic effectiveness. Optimum
response generally occurs within 2 wk (e.g., relief
of pain, stiffness, or swelling; or improved joint
flexion and strength).
 Monitor for GI distress and S&S of GI bleeding.
 Be alert for signs of drug-induced hepatitis,
including anorexia, abdominal pain, severe nausea
and vomiting, yellow skin or eyes, skin rashes, flu-
like symptoms, and muscle/joint pain. Report these
signs to the physician immediately.
 Monitor signs of allergic reactions and anaphylaxis,
including pulmonary symptoms (laryngeal edema,
wheezing, cough, dyspnea) or skin reactions (rash,
pruritus, urticaria). Be especially alert for
exfoliation, dermatitis, and other severe skin
reactions that might indicate serious
hypersensitivity reactions (Stevens-Johnson
syndrome, toxic epidermal necrolysis). Notify
physician immediately if these reactions occur.
 salicylates,
sulfinpyrazone, ticarcillin,
valproic acid, other anti-
inflammatories: Increases
risk of bleeding or
adverse GI reactions.
Avoid use together.
Aspirin: May decrease
bioavailability of
ibuprofen.
Insulin, oral antidiabetics:
May potentiate
hypoglycemic effects.
Dosage adjustment may
be needed.
Lithium, methotrexate:
Decreases renal
clearance of these drugs.
Use together cautiously.
Nifedipine, phenytoin,
verapamil: Toxicity may
occur. Avoid use
together.

Certification Date: 1 February 2021 Recertification due date: 24 January 2024 For verification of the certificate please access www.gcl-intl.com
(Certification check and type the registration number)
SDF-CON-304-071-00

Page 1 of 3

Registration No. 52Q18778

Republic of the Philippines
Cebu Normal University
Osmeña Blvd., Cebu City, 6000, Philippines

College of Nursing
Telephone No.: (+63 32) 254 4837
Email: cn@cnu.edu.ph
Website: www.cnu.edu.ph
 Frequency:
Q 6 hrs PRN

Availability/Form
and Contents:

Tablets: 300 mg, 400

mg, 600 mg, 800 mg
Oral drops: 40 mg/ml
Oral suspension: 100
mg/5 ml, 100 mg/2.5
ml
Tablets: 100 mg, 200
mg
Tablets (chewable):
50 mg, 100 mg

References (at least 2):

Glowm. (n.d.). ibuprofen. Retrieved March 3, 2022, from https://m.glowm.com/resources/glowm/cd/pages/drugs/ij000.html
McGraw Hill Medical. (n.d.). Ibuprofen, Oral. Retrieved March 3, 2022, from https://fadavispt.mhmedical.com/content.aspx?bookid=1873&sectionid=139013956
Rob Holland. (n.d.). IBUPROFEN. Retrieved March 3, 2022, from http://www.robholland.com/Nursing/Drug_Guide/data/monographframes/I002.html

Certification Date: 1 February 2021 Recertification due date: 24 January 2024 For verification of the certificate please access www.gcl-intl.com
(Certification check and type the registration number)
SDF-CON-304-071-00

Page 2 of 3

Registration No. 52Q18778

Republic of the Philippines

Cebu Normal University Osmeña

Blvd., Cebu City, 6000, Philippines
 College of Nursing
Telephone No.: (+63 32) 254 4837
Email: cn@cnu.edu.ph
Website: www.cnu.edu.ph

PRODUCT ASSESSMENT RUBRICS FOR DRUG STUDY

Student Name: ____Mendez, Mary April_____________________ Year/Section: ________BSN 4 - B____________ Date: ____March 1, 2022_____ Score: ___/30 Directions:

Please select the appropriate rating using the following descriptions.

Element Very Satisfactory Satisfactory Needs Improvement Comments

Drug ☐ Accurately presented all of the patient and drug ☐ Accurately presented most of the patient and drug ☐ Accurately presented some of the patient and drug
Information information (name [brand & generic], dosage [patient’s dose; information related to the case. 1 missing information or information related to the case. 2 or more missing information
(10%) min. & max], frequency, route, availability, contents) related error noted. [2] or errors noted. [1]
to the case. [3]

Classification ☐ Accurately presented the classification (therapeutic and ☐ Accurately presented the classification related to the ☐ Inaccurately presented the classification related to the drug.
(10%) pharmacologic) related to the drug. [3] drug but with 1 irrelevant information or error noted. [2] Classification is not relevant to the drug. [1]

Indication (10%) ☐ Accurately presented the indication/s (general & patient ☐ Accurately presented the indication/s related to the drug ☐ Inaccurately presented the indication/s related to the drug.
specific) related to the drug. [3] but with 1 irrelevant information or error noted. [2] Indication is not relevant to the drug. [1]

Mechanism of ☐ Accurately presented the mechanism of action ☐ Accurately presented the mechanism of action of the ☐ Inaccurately presented the mechanism of action of the drug.
Action (10%) (pharmacokinetics, pharmacodynamics) of the drug. [3] drug but with 1 irrelevant information or error noted. [2] Mechanism of action is not relevant to the drug. [1]

Contraindicati ☐ Accurately presented all of the common contraindications ☐ Accurately presented most of the common ☐ Accurately presented some of the common contraindications
on (10%) related to the drug. [3] contraindications related to the drug. 1 missing information related to the drug. 2 or more missing information or errors
or error noted. [2] noted. [1]

Side Effects ☐ Accurately presented all of the common side effects ☐ Accurately presented most of the common side effects ☐ Accurately presented some of the common side effects
(10%) related to the drug. [3] related to the drug. 1-2 missing information or errors noted. related to the drug. 3 or more missing information or errors
[2] noted. [1]

Nursing ☐ Accurately presented all of the common nursing ☐ Accurately presented most of the common nursing ☐ Accurately presented some of the common nursing
Responsibilit responsibilities (before, during, and after) related to the drug. responsibilities related to the drug. 1-2 missing information responsibilities related to the drug. 3 or more missing
ies (30%) [9] or errors noted. [7] information or errors noted. [3]

References ☐ Presented at least 2 sources that are updated (within 5 ☐ Presented only one source that is updated (within 5 ☐ No source was presented. Sources are not updated (more
(10%) years), relevant, and credible. [3] years), relevant, and credible. Other sources are not than 5 years), relevant, and credible. [1]
updated, credible or relevant. [2]

Sub-score = ____ = ____ = ____

Evaluated by:
______
Signature over Printed Name of Clinical Instructor
 Certification Date: 1 February 2021 Recertification due date: 24 January 2024 For verification of the certificate please access www.gcl-intl.com
(Certification check and type the registration number)
SDF-CON-304-071-00

Page 3 of 3

Registration No. 52Q18778